RxSight (NASDAQ:RXST) vs. Futureworld (OTCMKTS:FWDG) Head-To-Head Review

Futureworld (OTCMKTS:FWDG) and RxSight (NASDAQ:RXST) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations.

Valuation and Earnings

This table compares Futureworld and RxSight”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futureworld	N/A	N/A	N/A	N/A	N/A
RxSight	$134.48 million	1.91	-$38.94 million	($1.13)	-5.49

Futureworld has higher earnings, but lower revenue than RxSight.

Analyst Recommendations

This is a summary of current recommendations for Futureworld and RxSight, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Futureworld	0	0	0	0	0.00
RxSight	3	7	2	0	1.92

RxSight has a consensus price target of $8.50, indicating a potential upside of 36.99%. Given RxSight’s stronger consensus rating and higher probable upside, analysts clearly believe RxSight is more favorable than Futureworld.

Risk and Volatility

Futureworld has a beta of -0.12, indicating that its share price is 112% less volatile than the S&P 500. Comparatively, RxSight has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500.

Insider & Institutional Ownership

78.8% of RxSight shares are owned by institutional investors. 10.1% of RxSight shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Futureworld and RxSight’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Futureworld	N/A	N/A	N/A
RxSight	-36.58%	-17.01%	-15.12%

Summary

RxSight beats Futureworld on 7 of the 10 factors compared between the two stocks.

About Futureworld

FutureWorld Corp., together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of hemp/cannabis products, services, and technologies worldwide. The company provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation, and consultation for the industrial hemp and legal medicinal marijuana. It offers personal and professional tetrahydrocannabinoil and Cannabidiol test kits; pharmaceutical grade CBD oil solutions; URVape vaporizer pens, which are oil vaporizers for the e-cigarette, cannabis, and herbal vaping industry; CaNNaLyTiX, a dashboard controller system that allows various computer systems to be integrated throughout a cultivator's infrastructures; CaNNaTRAK, the barcode and RFID tracking systems for keeping seed to sale tracking of hemp/cannabis; and SPIDer (secure perimeter intrusion detection network), a system to meet the needs of theft and malicious attacks. The company also provides SmartSense, which offers wireless security and smart sensor mesh network for precision agriculture, irrigation systems, and greenhouses for the hemp industry; SmartNergy that offers tools to analyze various aspects of a cultivator's energy usage; and CaNNaBoX machine, which operates with the swipe of a card to verify identity, age, and prescription information of a medical marijuana patient before releasing measured packages of marijuana. Its target customers include consumers via Internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, affiliate sales, and master distributors. The company was formerly known as FutureWorld Energy, Inc. and changed its name to FutureWorld Corp. in June 2014. FutureWorld Corp. was founded in 2002 and is based in Saint Petersburg, Florida.

About RxSight

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.